ATLANTA, Sept. 12, 2013 /PRNewswire/ -- Elekta (booth #942) will exhibit its Versa HD system at the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 22-24 at the Georgia World Congress Center in Atlanta. In the six months since its introduction, Versa HD has been building momentum worldwide, with clinical users reporting exceptional speed and accuracy.
Versa HD embodies Elekta's theme for this year's ASTRO, The Power of Care, which emphasizes the synergy of technology and people working together to support positive patient outcomes. Versa HD reinforces this theme through its flexibility, speed and accuracy, in addition to a series of packages (spine, breast, prostate, head & neck, lung) designed to address unique clinical challenges making it easy to customize a system that meets clinic and patient needs. Versa HD delivers conventional therapies and treats complex cancers that require extreme accuracy all in a single system.
"Versa HD is the centerpiece of what will be one of Elekta's strongest ASTRO exhibitions ever," says Jay Hoey, Executive Vice President, Elekta North America. "We're covering every cancer management solution area with highly sophisticated, patient-centric products, encompassing treatment delivery and coordination, planning, imaging and immobilization."
Live Versa HD presentations will be held hourly on the Elekta booth.
Versa HD incorporates new solutions
Also to be featured as important new solutions for Versa HD will be XVI 5.0 (Elekta's X-ray volume imaging system) for intra-fraction imaging and Active Breathing Coordinator, providing automated gating. Supporting these clinical workflows will be Identify, which offers patient and accessory verification for users of Versa HD and other Elekta radiation therapy systems.
XVI 5.0 enables 3D and 4D intra-fraction imaging during VMAT delivery, and 2D intra-fraction imaging during static field delivery.
Active Breathing Coordinator now features automated breath hold gating for improved breast and lung radiotherapy. For anatomies affected by respiratory motion, such as lung, liver and breast, Active Breathing Coordinator provides non-invasive, internal immobilization of the target, triggering radiation delivery when the anatomy is immobilized.
Through radiofrequency identification (RFID) in real time, Identify verifies the right patient and their accessories required for treatment from the moment the patient enters the room increasing confidence and workflow efficiency.
ASTRO attendees invited to visit Elekta booth 942 for product demonstrations
- Monaco® - Introducing the next big step in treatment planning highlighting dose accuracy, workflow efficiencies, and performance
- Clarity® Autoscan Real-time soft tissue motion tracking during treatment
- MOSAIQ® Mobile Instant access to MOSAIQ from anywhere
- Flexitron® Optimized treatment delivery process for brachytherapy
- Leksell Gamma Knife® Perfexion Spotlight on patient safety and provider efficiency
To schedule a product demonstration, visit www.elekta.com/ASTRO.
Additional Elekta activities
The MOSAIQ Medical Oncology Summit is being held Friday, September 20 at the Marriott Marquis Atlanta.
The 22nd Annual Elekta Oncology Users Meeting (EOUM) convenes Saturday, September 21 at the Marriott Marquis Atlanta. Customers using any Elekta solution are welcome to attend and take advantage of this free educational opportunity. Leading cancer physician, researcher and Pulitzer Prize winner Siddhartha Mukherjee, M.D., Ph.D., will serve as keynote speaker. To learn more about the EOUM, visit www.elekta.com/EOUM2013.
The Elekta Charity Splash, benefiting Atlanta-based Brain Tumor Foundation for Children (BTFC), will be held September 21 from 8 - 11 p.m. at the Georgia Aquarium. Elekta is proud to support the BTFC, which serves children with brain tumors and their families. Tickets must be purchased in advance for this event and will not be sold at the door. One hundred percent of this year's charity event ticket proceeds will benefit the BTFC.
The grand opening of the Learning and Innovation Center (LINC) will be held Monday, September 23 at Elekta's Atlanta headquarters. The LINC is a brand new facility devoted to the education of health care professionals and Elekta employees on the latest Elekta solutions. The LINC fosters an ideal environment for learning, blending adult learning techniques with hands-on training. The LINC also features fully functional Versa HD and Leksell Gamma Knife Perfexion systems and the Flexitron afterloading platform.
Elekta's Capital Markets Day will be held Monday, September 23, from 9 - 11 a.m. at the Marriott Marquis Atlanta. Elekta's President and CEO, Tomas Puusepp, together with other members of Elekta's management team, will present the company and highlight the product and solutions portfolio. Visit elekta.com to watch live.
Follow the Elekta Twitter handle, @Elekta, for updates from the ASTRO show floor. If you would like to speak with an expert, require comments, quotes or insights regarding Elekta's solutions, contact Michelle Joiner at +1 678-938-4163.
MOSAIQ Mobile is a works in progress and not for sale in all markets. XVI 5.0 is pending FDA 510(k) clearance and not available for sale or distribution in the U.S. Identify and Versa HD are not available for sale in all markets. Please contact your local Elekta representative for more details.
For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: firstname.lastname@example.org
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: email@example.com
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.